Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Update

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the recipient of a large drop in short interest during the month of June. As of June 30th, there was short interest totaling 23,325 shares, a drop of 91.5% from the June 15th total of 273,134 shares. Currently, 1.2% of the shares of the company are short sold. Based on an average daily trading volume, of 95,314 shares, the short-interest ratio is currently 0.2 days.

Analysts Set New Price Targets

Separately, Weiss Ratings cut Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, June 25th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Sell”.

Arcadia Biosciences Price Performance

Shares of NASDAQ:RKDA traded up $0.01 during trading on Friday, hitting $0.68. The company’s stock had a trading volume of 44,798 shares, compared to its average volume of 1,490,680. The firm has a market cap of $1.49 million, a price-to-earnings ratio of -0.12 and a beta of 0.54. The company has a 50-day moving average of $0.90 and a 200-day moving average of $1.53. Arcadia Biosciences has a 12 month low of $0.63 and a 12 month high of $6.71.

Arcadia Biosciences (NASDAQ:RKDA) last announced its earnings results on Thursday, May 14th. The basic materials company reported ($2.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.80) by ($1.31). Arcadia Biosciences had a negative net margin of 195.94% and a negative return on equity of 113.73%. The business had revenue of $1.10 million for the quarter, compared to the consensus estimate of $1.60 million.

About Arcadia Biosciences

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.